Back
Relmada Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73
RLMD
Relmada Therapeutics, Inc.
Last Price:
$6.99
Seasonality Move:
7.57%
7 Day Trial
ALL ACCESS PASS
$
7
Relmada Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Relmada Therapeutics, Inc. has on average historically risen by 223.7% based on the past 11 years of stock performance.
-
Relmada Therapeutics, Inc. has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
-
Is Relmada Therapeutics, Inc. Stock Undervalued?The current Relmada Therapeutics, Inc. [RLMD] share price is $6.99. The Score for RLMD is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
RLMD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Relmada Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Relmada Therapeutics, Inc. has on average historically risen by 223.7% based on the past 11 years of stock performance.
Relmada Therapeutics, Inc. Stock Rating
Buy
73
Relmada Therapeutics, Inc. (RLMD)
is a Buy
Is Relmada Therapeutics, Inc. overpriced?
-
Relmada Therapeutics, Inc. has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
Relmada Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
relmada.com
52-Week Data
52-Week High:
7.51
52-Week Low:
0.24
Prediction Charts
Market Cap:
721.8M
Price in USD:
6.99
Volume:
1.8M
Beta:
0.42
Technical Analysis
SMA50:
4.99
SMA100:
4.57
SMA200:
2.92
52-Wk Change:
2206.17%
Stock Predictions
-
Is Relmada Therapeutics, Inc. stock public?Yes, Relmada Therapeutics, Inc. is a publicly traded company.
-
What is the Relmada Therapeutics, Inc. stock quote today?The Relmada Therapeutics, Inc. stock price is 6.99 USD today.
-
How to buy Relmada Therapeutics, Inc. stock online?You can buy Relmada Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 5.98 | 6.18 | 6.42 | 5.93 |
| Mar-17 | 6.18 | 6.45 | 6.48 | 6.18 |
| Mar-18 | 6.45 | 6.21 | 6.56 | 6.20 |
| Mar-19 | 6.21 | 6.25 | 6.32 | 5.93 |
| Mar-20 | 6.50 | 6.07 | 6.66 | 5.85 |
| Mar-23 | 6.07 | 5.86 | 6.15 | 5.71 |
| Mar-24 | 5.90 | 6.10 | 6.21 | 5.68 |
| Mar-25 | 6.19 | 6.66 | 6.74 | 6.19 |
| Mar-26 | 6.45 | 6.53 | 6.73 | 6.44 |
| Mar-27 | 6.46 | 6.43 | 6.65 | 6.32 |
| Mar-30 | 6.47 | 6.38 | 6.53 | 6.28 |
| Mar-31 | 6.51 | 6.96 | 6.96 | 6.38 |
| Apr-1 | 7.08 | 7.10 | 7.37 | 6.94 |
| Apr-2 | 6.86 | 6.99 | 7.05 | 6.60 |
Relmada Therapeutics, Inc. Earnings
Relmada Therapeutics, Inc. Earnings Report: Per Share Relmada Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Relmada Therapeutics, Inc. Forecast Revenue Growth
Relmada Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Relmada Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and a decrease next year of $0.00 per share.
* Relmada Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.